Banyan Biomarkers

Banyan Biomarkers, Inc. develops biomarkers for the diagnosis, management, and treatment of traumatic brain injury (TBI). Its product portfolio includes biomarkers for stroke, depression, hypoxic-ischemic encephalopathy (HIE), neuro ICU monitoring, and subacute/chronic TBI. The company also provides point-of-care blood tests to detect mild and moderate brain trauma in patients with head injuries.